Magellan Health (MGLN) Tops Q4 EPS Expectations

Magellan Health (NASDAQ: MGLN) reported Q4 EPS of $1.39, $0.56 better than the analyst estimate of $0.83. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.22 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
• Elevance (ELV) PT Raised to $482 at Bernstein SocGen